I took a brief break from overseeing CURE’s research efforts last week to attend a CURE Benefit in Boston hosted by Anne Finucane & Mike Barnicle as well as Susan & David Axelrod. I’m so grateful to them for being such wonderful hosts and would like to thank all those who attended. At the event, CURE’s founder Susan Axelrod spoke about the importance of epilepsy research and highlighted our plans to work with the Department of Defense on Post-Traumatic Epilepsy. I had the opportunity to speak about recent CURE-funded research that may lead to important diagnostic and treatment advances.
The 2018 Boston Benefit for the Cure was a wonderful opportunity to get together with members of our passionate community who are dedicated to finding a cure.
Couldn’t attend the Boston event? Read on… you can participate in other ways. Our next online webinar will feature news about promising anti-epileptic drugs in development. Or, if you’re looking to attend an event in-person, I’ve included information about CURE’s next Day of Science events as well as additional news and events that I’m excited to share with you.
Dr. Laura Lubbers
PROMISING ANTI-EPILEPTIC DRUGS IN DEVELOPMENT ? WEBINAR
This free webinar will outline therapies in development for epilepsy and seizures, including promising therapies for patients with treatment-resistant epilepsy and children with severe epilepsy. The webinar will also focus on drugs that may not only reduce seizures, but improve treatment of the underlying disease.
The webinar will be presented by Dr. Jacqueline French, a professor of Neurology in the Comprehensive Epilepsy Center at NYU Langone School of Medicine and Founder/Director of the Epilepsy Study Consortium. Dr. French’s presentation will be followed by an interactive Q&A session.
The information session is scheduled for Wednesday, April 18, 2018 at 1pm EDT / 2pm CDT. The webinar is free, but you do need to register.